News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TransTech Pharma, Inc. and High Point Pharmaceuticals Awarded $1.96 Million in Grants for Qualifying Therapeutic Development Projects


11/5/2010 9:59:33 AM

HIGH POINT, N.C.--(BUSINESS WIRE)--TransTech Pharma, Inc. and High Point Pharmaceuticals, LLC. today announced that they have been awarded cash grants totaling $1.96 million under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) program.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES